Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
hearX is a digital technology provider focused on hearing health. Founded in 2016, it aims to improve access to hearing care through smart screening and testing devices. Its products cover clinical use, large-scale screening, occupational hearing conservation, and retail settings. The main value proposition is enabling professionals to conduct on-site hearing assessments without a sound booth, reducing requirements around venue, deployment, and time.
Based on the available text, hearX’s software and services include hearX Cloud, hearScreen, hearTest, hearTest Occ Health, hearDigits, hearX Self Test Kit, hearOAE, as well as a web portal and the hearX App. It also showcases mobile screening app cases such as hearWHO and Höra, using digits-in-noise technology to support public pre-screening for hearing issues. Deployment appears to be primarily cloud-based, via online portals and mobile apps; no self-hosted option was found. Note that the terms clearly state the services are intended to indicate potential hearing problems and should not replace professional medical diagnosis.
hearX does not disclose specific plan pricing in the captured text. Fees are subject to the website, quotations, or invoices. Some costs, such as hardware, must be prepaid. Annual software licenses can be paid upfront or monthly over 12 months, and they do not renew automatically. The website offers free resources and the option to book a free online product demo, but it does not specify whether a free plan or self-service trial is available.
Its compliance disclosures are relatively comprehensive: hearX states that it has completed a SOC 2 Type II audit and lists FDA Registered, ISO 13485 Certified, SAHPRA Registered, HIPAA, GDPR, and POPIA compliance. In terms of teams and permissions, the text mainly emphasizes that users are responsible for managing account allocation, canceling accounts for departed or unauthorized personnel, password security, and data backups. More granular permission capabilities such as RBAC or audit logs are not disclosed. For data, users must obtain patient consent, and uploaded data may be anonymized or aggregated for research and product improvement.
Its strengths include a clear vertical focus, strong emphasis on clinical validation, no need for a sound booth, and a solid compliance foundation. It is suitable for healthcare institutions, occupational health service providers, hearing screening programs, and retailers that need in-store or online testing. Limitations include opaque pricing, and real-world deployment may involve hardware, calibration, regional regulation, and medical data compliance, making procurement and implementation relatively complex. Information on APIs, third-party integrations, and advanced permissions is also limited.
The website’s form country list includes China, and hearWHO supports Mandarin, but the text does not provide information on access speed from mainland China, localized payments, or domestic compliance. Therefore, China access remains unknown. For deployment in China, key areas to evaluate include network connectivity, medical device and health data compliance, local payment options, and after-sales support. Potential alternatives include local hearing screening device vendors, hospital IT providers, or occupational health management systems.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on hearxgroup.com official site.
hearxgroup.com is an South Africa Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach hearxgroup.com directly.